“…In contrast, the inability of corroles to penetrate cell membranes without a carrier protein can avoid such detrimental side effects, should the corrole release prematurely from the carrier before reaching a target cell. This is an unlikely possibility, however, due to the high degree of binding stability to endure ultrafiltration, HPLC, and nonexchange with serum protein (5,6). Our studies here further confirm that the targeted complex retains integrity in human serum, localizes tumors in vivo, and elicits tumor cell death while sparing healthy tissue such as the heart.…”